维普中文期刊产品整合服务
23篇 您的检索式:作者名="DIEMBERGER I"
    题名 作者 年代 出处 被引量
1Pharmacological cardioversion of atrial fibrillation: current management and treatment options显示文摘BORIANI G DIEMBERGER I BIFFI M 2004Drugs2004,64,24:1
2Rate control in atrial fibrillation : choice of treatment and assessment of efficacy 显示文摘BORIANI G BIFFI M DIEMBERGER I 2003Drugs2003,63,14:1
3Pharmacological cardioversion of atrial fibrillation:current management and treatment options显示文摘Boriani G Diemberger I Biffi M 2004Drugs2004,64,24:1
4Atrial fibrillation: adverse effects of 'pill-in-the-pocket' treatment and propafenone- carvedilol interaction显示文摘Boriani G Biffi M Diemberger I 2010Int J Cardiol2010,140,2:1
5Rate control in atrial fibrillation:choice of treatment and assessment of efficacy显示文摘Boriani G Biffi M Diemberger I 2003Drugs2003,63,:1
6Pharmacological cardioversion of atrial fibrillation:current management and treatment options显示文摘BORIANI G DIEMBERGER I BIFFI M 2004Drugs2004,64,24:1
7Prevention ofinfections in cardiovascular implantahle electronic devices beyond the antibiotic agent显示文摘De Maria E Diemberger I Vassallo PL 2014J Cardiovasc Med2014,15,7:1
8Pharmacological cardioversion of atrial fibrillation : current management and treatment options 显示文摘Boriani G Diemberger I Biffi M 2004Drugs2004,64,24:1
9Pharmacological cardioverslon of atrial fibrillation: current management and treatment options显示文摘BORIANI G DIEMBERGER I BIFFI M 2004Drugs2004,64,24:1
10Troponin I rise after pacemaker implantation at the time of 'universal defi- nition of myocardial infarction' 显示文摘Martignani C Diemberger I Biffi M 2009Am J Cardiol2009,103,8:1
11Troponin I rise after pacemaker implantation at the time of 'universal defi- nition of myocardial infarction' 显示文摘Martignani C Diemberger I Biffi M 2009The American journal of cardiology2009,103,8:1
12Pharmacological eardioversion of atrial fibrillation: current management and treatment options显示文摘BORIANI G DIEMBERGER I BIFFI M etal 2004Drugs2004,64,24:1
13Rate control in atrial fibrillation: choice of treatment and assessment of efficacy 显示文摘Boriani G Biffi M Diemberger I 2003Drugs2003,63,14:1
14From lead managementto implanted patient management:indications to lead extraction inpacemaker and cardioverter-defibrillator systems 显示文摘Diemberger I’Biffi M Martignani C 2011Expert RevMed Devices2011,8,2:1
15Pharmacological cardioversion of atrial fibrillation: current management and treatment options显示文摘Boriani G Diemberger I Bifli M 2004Drugs2004,64,24:1
16Pharmacological cardioversion of atrial fibrillation:current management and treatment options显示文摘Boriani G Diemberger I Biffi M 2004Drugs2004,64,24:1
17Pharmacological cardioversion of atrial fibrillation: current management and treatment options显示文摘Boriani G Diemberger I BiffiM 2004Drugs2004,64,24:1
18From lead management to implanted patient management:indications to lead extraction in pace- maker and cardioverter- defibrillator systems 显示文摘Diemberger I Biffi M Martignani C 2011Expert Rev Med Devices2011,8,2:1
19Potential of nonantiarrhythmic drugs to provide an innovative upstream approach to the pharmacological prevention of sudden cardiac death显示文摘Boriani G Valzania C Diemberger I 2007Expert Opin Investiga Drugs2007,16,5:1
20Rate control in atrial fibrillation :choice of treatment and assessment of efficacy 显示文摘Boriani G Biffi M Diemberger I 2003Drugs2003,63,14:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费